SpaceRISE selected by European Commission to build and operate the IRIS ² multi-orbit satellite constellation
SpaceRISE, the consortium comprising Eutelsat (ISIN: FR0010221234 - Euronext Paris / London Stock Exchange: ETL), Hispasat and SES (Ticker: SESG), together with other core members, is pleased to announce it has been awarded by the European Commission to design, deliver, and operate IRIS², the European Union’s pioneering multi-orbit connectivity system. This milestone represents a crucial step towards establishing a secure, resilient, and autonomous communications infrastructure for Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241031794269/en/
Interconnected Multi-Orbit System. Credit: SES
IRIS² will play a transformative role in reinforcing Europe’s resilience, digital sovereignty, and low-latency connectivity for all EU Member States. This IRIS² multi-orbit satellite system is intended to enhance Europe’s ability to respond to crises, protect essential infrastructure, and bridge the digital divide. With full operational status targeted for the early 2030s, IRIS² will deliver a secure and competitive communications backbone aligned with Europe’s strategic and digital priorities.
The IRIS2 programme is a public private partnership (PPP) which will be funded by a combination of EU, European Space Agency and private financing from the three satellite operators within the SpaceRISE consortium.
The consortium looks forward to the final phase of the procurement process leading to contract signature expected by the year end.
Eva Berneke, Chief Executive Officer of Eutelsat commented: “The IRIS² programme is a powerful extension of Eutelsat’s commitment to advancing Europe’s digital sovereignty through sustained investment in multi-orbit technology to deliver multi-layered, low-latency networks, which are essential to Europe’s strategic resilience. We are proud to support the EU on this project alongside the consortium partners to deliver a resilient, future-ready communication system that meets Europe’s most critical connectivity needs, while generating value-creation for Eutelsat and its stakeholders by complementing and enhancing our existing LEO capabilities."
Miguel Ángel Panduro, Chief Executive Officer of Hispasat added: "We are firmly committed to everything that IRIS² represents: a sovereign secure communications system, supported by European innovative developments and driven by public-private partnership. It is an ambitious project, in which the companies of the SpaceRISE consortium are working to offer the best response to the demands of the European Union. This award is an exciting first step of a project that will define the future of satellite communications in Europe."
Adel Al-Saleh, Chief Executive Officer of SES said:“Being selected as a trusted partner for IRIS² is an honour. SpaceRISE, based on the European Union’s requirements will define and develop a future-proof space network that will serve as the cornerstone of Europe’s space and defence strategies in the years to come. The IRIS² system is aligned with SES’s multi-orbit network and underscores our commitment to advancing our MEO capabilities, as well as having access to LEO orbit. We will continue to ensure that the contract meets our IRR requirements, cash generation fundamentals, and investment grade metrics.”
About SpaceRISE
SpaceRISE which stands for Space Consortium for a Resilient, Interconnected and Secure Europe isdedicated to fostering a resilient, interconnected, and secure Europe through space innovation. Comprising Europe’s key space and telecom companies including Airbus Defence and Space, Deutsche Telekom, Eutelsat, Hisdesat, Hispasat, OHB, Orange, SES, Telespazio, Thales Alenia Space, and Thales, SpaceRISE aims to bring SMEs and New Space players together in a multi-national footprint throughout the EU27 Member States to expand its collaboration. By harnessing the strengths of established industry leaders and emerging innovators, SpaceRISE is set to drive Europe’s secure and sustainable future in space.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241031794269/en/
Contacts
Joanna Darlington
Anita Baltagi
Eutelsat
+33 6 74 52 15 31
+33 6 43 93 01 78
jdarlington@eutelsat.com
abaltagi@eutelsat.com
www.eutelsat.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.eutelsat.co
m&esheet=54145525&newsitemid=20241031794269&lan=en-US&anchor=www.eutelsat.com&in
dex=2&md5=a964498c35d6644da3ef749db43b372b
Víctor Inchausti
Hispasat
+34 667 31 29 48
vinchausti@hispasat.com
www.hispasat.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.hispasat.co
m&esheet=54145525&newsitemid=20241031794269&lan=en-US&anchor=www.hispasat.com&in
dex=3&md5=6f7a2f2f616c2136991e5f3da105779d
Suzanne Ong
SES
+352710725500
suzanne.ong@ses.com
www.ses.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ses.com&esh
eet=54145525&newsitemid=20241031794269&lan=en-US&anchor=www.ses.com&index=4&md5=
6d97d90fd1a7bd55419f9ba231c1ca28
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Neutrogena ® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists31.10.2024 22:15:00 EET | Press release
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced its Neutrogena® brand is taking dermatological beauty to the next level by establishing multi-year partnerships with Dr. Dhaval Bhanusali, renowned skincare innovator, and Dr. Muneeb Shah, the most followed dermatologist worldwide2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241031619557/en/ (Photo: Business Wire) This collaboration reinforces Neutrogena®’s commitment to fusing beauty and science to deliver advanced clinical efficacy and extraordinary product experiences. It also builds on existing partnerships with a diverse network of global dermatologists who are actively involved in product development, clinical studies, and educational initiatives. Looking ahead, Neutrogena® aims to advance the science of dermatology to better address gaps in the category and help shape the future of skincare by inc
NetApp Elevates Pamela Hennard to Chief Diversity and Inclusion Officer, Accelerating its Vision for a More Inclusive Future31.10.2024 18:00:00 EET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced the appointment of Pamela Hennard as the new Chief Diversity and Inclusion Officer. In her expanded role, Pamela will lead NetApp's efforts to foster diversity, equity, and inclusion across the organization and within the talent acquisition process and throughout the full employee journey. Pamela Hennard has been an integral part of NetApp's success, serving as the Vice President of Global Talent Acquisition. With over 27 years of experience in human resources, Pamela brings a wealth of expertise in developing and leading high-performing teams. During Pam’s tenure at NetApp, her strategic guidance has been instrumental in setting and achieving recruitment and onboarding objectives, while also aligning with diversity, inclusion, and belonging initiatives. Throughout her career, Pamela has been a staunch advocate for diversity and inclusion, working to integrate these principles into human resources proc
ELIQUENT Life Sciences Announces: Rob Wojciechowski Joins Firm31.10.2024 16:39:00 EET | Press release
ELIQUENT Life Sciences (ELIQUENT), a global regulatory consulting firm, today announced the appointment of Rob Wojciechowski as Managing Director of the Consulting Practice across Europe and the Asia-Pacific region. This strategic addition to ELIQUENT’s executive team underscores the company’s commitment to continued growth within European and Asian markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241031868837/en/ Rob Wojciechowski (Photo: Business Wire) “Rob’s appointment comes at a pivotal moment for ELIQUENT. His extensive experience in managing consulting practices across diverse markets will be instrumental in expanding our footprint and enhancing our service offerings to meet the unique needs of clients in Europe and the APAC region,” said Tim Dietlin, Chief Executive Officer, ELIQUENT Life Sciences. A seasoned life sciences executive and NED board member, Rob brings an extensive background in leadership, strate
Xsolla and Long Tale Games Launch Charity Campaign With Life Is Feudal to Support Games for Change31.10.2024 15:00:00 EET | Press release
Xsolla, a global video game commerce company, has partnered with Long Tale Games to launch a charity campaign. 50% of the proceeds from the 3-month subscription package to Life is Feudal will be donatedto Games For Change. This initiative, running until December 31st, reflects Xsolla’s commitment to leveraging the power of gaming to drive positive change. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241031878088/en/ (Graphic: Xsolla) The campaign offers players an exciting adventure in Life is Feudal: MMO and allows them to make a tangible impact. With half of each 3-month subscription supporting educational programs, civic engagement initiatives, and social impact projects, the campaign demonstrates how gaming can foster a better future through the power of play. Players are empowered to engage with a meaningful cause, proving that games are more than just entertainment—they are a way to support causes that matter. "Gamin
Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution31.10.2024 14:00:00 EET | Press release
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has introduced two new bundled offerings to meet the growing demands of oncology and vaccine research. Medidata Oncology Solutions and Medidata Vaccine Solutions reinforce the FDA guidance for patient-centered endpoints, adaptive trial designs, and trial diversity. By unifying key trial components such as real-time patient-reported outcomes and imaging management, these bundled solutions will aid sponsors by reducing trial complexity, accelerating decision-making, and improving assessments of treatment efficacy and safety. "Oncology and vaccine trials face significant challenges in recruiting diverse patients, ensuring rapid execution, and maintaining and monitoring patient safety," said Joseph Schmidt, chief operating officer, Medidata. "By making these new bundled capabilities readily available to customers, we can deliver a solution built on Medidata’s vast experience
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom